This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Gerhard Christofori: Innovator in Recombinant Virus Technology
Introduction
Gerhard Christofori is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses for various applications. His innovative work has implications for both veterinary and human medicine.
Latest Patents
Christofori holds a patent for a recombinant CELO virus and CELO virus DNA. This invention features a deletion at the right end of the viral genome, allowing for the insertion of large pieces of foreign DNA. The recombinant virus is particularly useful as a vaccine for animals, especially birds, and has potential applications in gene therapy and vaccine development for humans. Additionally, it can be utilized for recombinant protein production.
Career Highlights
Gerhard Christofori is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has focused on advancing viral vector technology, which is crucial for developing effective vaccines and therapeutic solutions.
Collaborations
Throughout his career, Christofori has collaborated with talented professionals in the field, including Amelia Compagni and Anne-Isabelle Michou. These collaborations have enhanced the research and development efforts in recombinant virus technology.
Conclusion
Gerhard Christofori's contributions to recombinant virus technology exemplify the innovative spirit of modern biotechnology. His work not only advances scientific knowledge but also holds promise for improving health outcomes in both animals and humans.